Connect with us

Spread & Containment

4 Hot Health Care Stocks To Watch Right Now

Could rising coronavirus cases globally see these health care stocks be put back into the limelight?
The post 4 Hot Health Care Stocks To Watch Right Now appeared first on Stock Market News, Quotes, Charts and Financial Information |



Are These The Best Health Care Stocks To Buy Right Now?

Whether it is health care stocks, vaccine stocks, or telehealth stocks, investors appear to be eyeing the health care world. For the most part, this would be the case in the stock market today as Covid-19 appears to be returning. Namely, parts of Europe are seeing a resurgence in daily cases as the highly transmissible Delta variant continues to rage on. In fact, the World Health Organization (WHO) estimates that Europe and Central Asia could suffer another 700,000 Covid-19 deaths by spring. Because of all this, the importance of the health care industry is yet again at the forefront.

On one hand, companies like Pfizer (NYSE: PFE) and CVS Health (NYSE: CVS) could be go-to’s for investors now. Accordingly, these are firms that have and continue to play crucial roles in the fight against the pandemic. This is apparent from Pfizer releasing new Covid-19 treatments to CVS administering millions of Covid tests and vaccines. On the other hand, there is also no shortage of emerging names to consider in the biotech field. Take Biofrontera (NASDAQ: BFRI) for example. The company specializes in the commercialization of dermatological products. Thanks to positive coverage from Roth Capital analyst Jonathan Aschoff, BFRI stock has more than doubled in value just this week. With all that said, could one of these health care stocks be worth watching in the stock market now?

Top Health Care Stocks To Watch In December 2021

Longeveron Inc.

To begin with, we will be taking a look at Longeveron. In brief, it is a clinical-stage biotech company that develops cellular therapies. Aging-related and life-threatening conditions are among the company’s key therapeutic areas of focus now. Notably, Longeveron’s flagship product is Lomecel-B, a treatment derived from culture-expanded medicinal signaling cells (MSCs). The likes of which are sourced from the bone marrow of healthy donors. Thanks to the company’s latest update on Lomecel-B, LGVN stock continues to soar in the stock market today.

LGVN stock

As it stands, the company’s shares are up by over 1,000% since the initial update on November 18. For the uninitiated, Longeveron’s Lomecel-B treatment received rare pediatric disease (RPD) status from the U.S. FDA. The approval is for the drug being used as a treatment of a heart defect in infants known as Hypoplastic Left Heart Syndrome.

Now, current estimates suggest that about 1,000 babies are born with this disease annually. While the market may be limited, investors appear to view this as a major regulatory win for Longeveron. Time will tell if the company can make the most of this approval in the long term. As such, will you be keeping an eye on LGVN stock?

[Read More] Best Lithium Battery Stocks To Buy Now? 4 To Know

Teladoc Health Inc.

Teladoc Health is a health care company that provides telemedicine and virtual health care to its customers. It allows its users to have access to health care, anywhere around the world on their terms. Using its proprietary health signals and personalized interactions, the company can give better health outcomes across the full continuum of care.

best tech stocks (TDOC stock)

Furthermore, Teladoc leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of both consumers and health care professionals.

Last month, the company reported its third-quarter financials. To begin with, revenue grew by 81% year-over-year to $522 million. This was driven by a total quarter visits that topped 3.9 million, 37% higher than a year ago. The company also made significant new agreements with CVS Health and Centene (NYSE: CNC) to provide Teladoc Health’s Primary360 to deliver greater care access and health engagement. Given the impressive financials, will you consider adding TDOC stock to your watchlist?

[Read More] 4 Artificial Intelligence Stocks To Watch Right Now

Novavax Inc.

Following that, we have Novavax, a biotechnology company that is developing and commercializing its proprietary recombinant technology platform that harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles. Also, the company is currently evaluating a Covid-NanoFlu combination vaccine in a Phase 1/2 clinical trial, which combines the company’s Covid-19 and influenza vaccine candidates.

best biotech stocks (NVAX stock)

Yesterday, the company announced that it has submitted to the Singapore Health Sciences Authority (HSA) for the interim authorization of its Covid-19 vaccine under the Pandemic Special Access Route (PSAR).

Today’s filing reinforces our ongoing commitment to delivering our COVID-19 vaccine, built on a proven, well-understood vaccine platform, to help end the pandemic,” said Stanley C. Erck, President, and Chief Executive Officer, Novavax. “Each additional market submission marks further progress in delivering our vaccine to the world, which we believe may help address major obstacles to global vaccination, including global distribution challenges and vaccine hesitancy.” With that being said, is NVAX stock worth investing in right now?

[Read More] 5 Metaverse Stocks To Watch In November 2021

Merck & Co Inc.

Merck is a health care company that brought forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of its mission to save and improve lives. Impressively, with over 130 years of experience, the company continues to be at the forefront of research to prevent and treat diseases that threaten people and animals.

biotech stocks (MRK stock)

On November 22, 2021, the company announced that it has completed the acquisition of Acceleron Pharma. The acquisition will continue to grow Merck’s cardiovascular portfolio and pipeline. Fueled by Acceleron’s groundbreaking research, the company says that it will explore the opportunities and possibilities ahead to reach even more patients by addressing this critical health need.

Acceleron is focused on harnessing the power of the transforming growth factor (TGF)-beta superfamily of proteins that are known to play a central role in the regulation of cell growth, differentiation, and repair. Given this piece of news, should you consider watching MRK stock?

The post 4 Hot Health Care Stocks To Watch Right Now appeared first on Stock Market News, Quotes, Charts and Financial Information |

Read More

Continue Reading


“The Omicron Variant” – Magic Pills, Or Solving The Africa Problem?

"The Omicron Variant" – Magic Pills, Or Solving The Africa Problem?

Authored by Kit Knightly via,

Yesterday the WHO labelled the sars-cov-2 variant B.1.1.529 as a “variant of concern” and officially named it “Omicron”.




"The Omicron Variant" – Magic Pills, Or Solving The Africa Problem?

Authored by Kit Knightly via,

Yesterday the WHO labelled the sars-cov-2 variant B.1.1.529 as a “variant of concern” and officially named it “Omicron”.

This was as entirely predictable as it is completely meaningless. The “variants” are just tools to stretch the story out and keep people on their toes.

If you want to know exactly how the Omicron variant is going to affect the narrative, well The Guardian has done a handy “here’s all the bullshit we’re gonna sell you over the next couple of weeks” guide:

  • The Omicron variant is more transmissable, but they don’t know if it’s more dangerous yet (keeping their options open)

  • It originated in Africa, possible mutating in an “untreated AIDS patient” (sick people are breeding grounds for dangerous “mutations”)

  • “it has more than double the mutations of Delta…scientists anticipate that the virus will be more likely to infect – or reinfect – people who have immunity to earlier variants. (undermining natural immunity, selling more boosters, keeping the scarefest going)

  • “Scientists are concerned” that current vaccines may not be as effective against the new strain, they may need to be “tweaked” (get your boosters, and the new booster we haven’t invented yet)

  • “Scientists expect that recently approved antiviral drugs, such as Merck’s pill, will work as effectively against the new variant” (more on this later)

  • It’s already spreading around the world, and travel bans may be needed to prevent the need for another lockdown

We’re already seeing preparations for more “public health measures”, with the press breathlessly quoting “concerned” public health officials. We’re being told that a new lockdown won’t be necessary…as long as we remember to get boosted and wear masks and blah blah blah.

Generally speaking, it’s all fairly boilerplate scary nonsense. Although it is quite funny that the Biden administration has already put a bunch of African nations on a travel ban list, when Biden called Trump a racist for doing the same thing in 2020.


It’s interesting that the new variant has allegedly come from Africa, perhaps “mutating in the body of an AIDS patient”, since Africa has been the biggest hole in the Covid narrative for well over a year.

Africa is by far the poorest continent, it is densely populated, malnourishment and extreme poverty are endemic across many African nations, and it is home to more AIDS patients than the entire rest of the world combined. And yet, no Covid crisis.

This is a weak point in the story, and always has been.

Last Summer, the UK’s virus modeller-in-chief Neil Ferguson attempted to explain it by arguing that African nations have, on average, younger populations than the rest of the world, and Covid is only a threat to the elderly. But five minutes of common sense debunks that idea.

The reason Africa has a younger population, on average, is that – on average – they are much sicker.

There are diseases endemic to large parts of Africa that are all but wiped out in most of the Western world. Cholera, typhus, yellow fever, tuberculosis, malaria. Access to clean water, and healthcare are also much more limited.

And while it has been nailed into the public mind that being elderly is the biggest risk factor for Covid, that is inaccurate. In fact, the biggest risk factor for dying “of Covid” is, and always has been, already dying of something else.

The truth is that any REAL dangerous respiratory virus would have cut a bloody swath across the entire continent.

Instead, as recently as last week, we were getting articles about how Africa “escaped Covid”, and the continent’s low covid deaths with only 6% of people vaccinated is “mystifying” and “baffling” scientists.

Politically, African nations have shown themselves far less likely to buy into the “pandemic” narrative than their European, Asian or American counterparts. At least two “Covid denying” African presidents – Pierre Nkurunziza of Burundi and John Magufuli of Tanzania – have died suddenly in the last year, and seen their successors immediately reverse their covid policies.

So maybe the Omicron Variant is a way of trying to fold Africa into the covid narrative that the other continents have already fully embraced. That will become clear as the story develops.

Of course, it’s also true that being “African” is media shorthand for being scary, relying on the deeply-seated xenophobia of Western audiences. See: “Africanized killer bees”.

But, either way, Africa is the long game. There’s a more obvious, and more cynical, short term agenda here.


Let’s go back to the Guardian’s “Omicron” bullet points, above:

  • Scientists are concerned by the number of mutations and the fact some of them have already been linked to an ability to evade existing [vaccine-created] immune protection.

  • Scientists expect that recently approved antiviral drugs, such as Merck’s pill, [will work effectively] against the new variant

The “new variant” is already being described as potentially resistant to the vaccines, but NOT the new anti-viral medications.

Pharmaceutical giants Merck and Pfizer are both working on “Covid pills”, which as recently as three days ago, were being hyped up in the press:

US may have a ‘game changer’ new Covid pill soon, but its success will hinge on rapid testing

In the US, an emergency use authorisation can only be issued if there is no effective medication or treatment already available, so the vaccines not being proof against Omicron would be vital to rushing the pills onto the US market, at least.

If Omicron is found to be “resistant to the vaccines”, but NOT the pills, that will give governments an excuse to rush through approving the pills on an EUA, just as they did with the vaccines.

So, you bet your ass that testing is gonna be “rapid”. Super rapid. Blink-and-you’ll-miss-it rapid. Rapid to the point you’re not even sure it definitely happened. And now they have an excuse.

Really, it’s all just more of the same.

A scare before the new year. An excuse to make people believe their Christmas could be in peril. An exercise in flexing their control muscles a bit, milking even more money out of the double-jabbed and boosted crowd, now newly terrified of the Omicron variant, and a nice holiday bump to Pfizer’s ever-inflating stock price.

At this point either you can see the pattern, or you can’t. You’re free of the fear machinery, or you’re not.

There is one potential silver lining here: It feels rushed and frantic. Discovered on Tuesday, named on Friday, travel bans on Saturday. It is hurried, and maybe that’s a reaction to feeling like the “pandemic” is losing its grip on the public mind.

Hopefully, as the narrative becomes more and more absurd, more and more people will wake up to reality.

It has been pointed out that “Omicron” is an anagram of “moronic”.

One wonders if that’s deliberate and they’re making fun of us.

Tyler Durden Sat, 11/27/2021 - 23:45

Read More

Continue Reading

Spread & Containment

Israel Moves To Ban All Foreigners From Entry Amid Omicron Variant Fears

Israel Moves To Ban All Foreigners From Entry Amid Omicron Variant Fears

Israel’s Knesset is set to hold a special emergency "coronavirus cabinet" late Saturday night where government officials will vote on enacting a complete closure of…



Israel Moves To Ban All Foreigners From Entry Amid Omicron Variant Fears

Israel's Knesset is set to hold a special emergency "coronavirus cabinet" late Saturday night where government officials will vote on enacting a complete closure of the country to foreign travel. The ban will tentatively be in effect for the next two weeks.

Already Israel has banned all foreigners arriving from the majority of African countries in recent days on fears that the highly-mutated Omicron coronavirus variant, which first emerged in South Africa, could be the next deadly wave - and with the vaccine possibly doing little to stop it.

AFP/Getty Images

The greatly tightened travel and tourist restrictions are expected to be announced late Saturday night or early Sunday. It's expected to also include a new mandatory quarantine of three days or more for vaccinated Israeli citizens who've returned from traveling abroad. For unvaccinated inbound Israeli citizens the quarantine will be a week.

The fresh travel rules come as authorities scramble to do contact tracing on exposures related to at least one confirmed Omicron case:

Authorities are scrambling to locate 800 Israelis who may have been exposed to the new Omicron variant of COVID-19, a defense official said Saturday.

The Health Ministry confirmed one case of the new variant in Israel, and said there were seven other suspected cases who were awaiting test results.

Four of the suspected cases returned to Israel recently from international travel, and three had not traveled, raising fears of community transmission in Israel.

Prime Minister Bennett ahead of the vote said the government is "preparing for any scenario." And concerning the new still somewhat mysterious variant, the country's interior minister said, "It looks like it might be more infectious, so we’re taking action as fast as possible."

Just days ago the health minister Nitzan Horowitz announced that Israelis will likely have to get a fourth shot, also as children between the ages of 5 to 11 have begun receiving the jab. Ironically the foreign tourist ban is now being re-imposed for one of the most highly vaxxed nations on earth.

At least 80% of all Israelis 16 and older are now considered fully vaccinated.

Tyler Durden Sat, 11/27/2021 - 23:15

Read More

Continue Reading


Mexican Authorities List Conditions To Reboot “Remain In Mexico” Program

Mexican Authorities List Conditions To Reboot "Remain In Mexico" Program

Authored by Tom Ozimek via The Epoch Times,

Mexican authorities have laid out a series of conditions for reviving the “Remain in Mexico” program, the Trump-era…



Mexican Authorities List Conditions To Reboot "Remain In Mexico" Program

Authored by Tom Ozimek via The Epoch Times,

Mexican authorities have laid out a series of conditions for reviving the “Remain in Mexico” program, the Trump-era framework under which asylum-seekers were returned to Mexico to await the processing of their claims, with the development coming in context of the Biden administration’s plans to reinstate the policy following a court order.

Mexico’s Foreign Ministry said in a Nov. 26 announcement that talks have “intensified” with the United States on rebooting the program, known as the Migrant Protection Protocols (MPP), but that Mexican authorities are waiting for a formal response from the Biden administration on a number of concerns.

“The government of Mexico … has raised various concerns of a humanitarian nature regarding the asylum procedure in the United States,” the ministry said, adding that it has “highlighted the need to improve conditions for migrants and asylum seekers, so that they have better legal advice” regarding the processing of their clams, which Mexico said, “must be carried out as expeditiously as possible.”

One of the conditions is for the United States to accelerate development programs for southern Mexico and Central America in order to address the root causes of migration.

Another is for Washington to offer individuals deported under the MPP program medical care and vaccination against COVID-19 “to protect their right to health and prevent the spread of COVID-19 in communities on both sides of the border.”

Mexico has also requested that the United States respect designated return points, taking into account local security conditions and the capacity of Mexican authorities “to provide adequate care to migrants.”

Another “essential” request is for Washington to provide funding for shelters and non-government organizations “in order to improve conditions for migrants and asylum seekers in a substantive way.”

The demands come as talks between the two countries continue on reimplementing the MPP program after a court in August ordered that the Department of Homeland Security (DHS) reverse its June decision to halt the policy.

“In compliance with the court order, we are working to reimplement MPP as promptly as possible,” DHS spokesperson Marsha Espinosa told Axios.

”We cannot do so until we have the independent agreement from the Government of Mexico to accept those we seek to enroll in MPP,” Espinosa added.

“We will communicate to the court, and to the public, the timing of reimplementation when we are prepared to do so.”

The Biden administration is facing an unprecedented surge in illegal immigration that critics say is fostered by its lax enforcement policies, including halting MPP and curtailing the use of Title 42, which is used to expel illegal immigrants during the COVID-19 pandemic.

Tyler Durden Sat, 11/27/2021 - 16:45

Read More

Continue Reading